SWOT Analysis for Ipca Laboratories Ltd.

Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
Expensive Performers (DVM)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Companies with rising net profit margins - quarterly as well as TTM basis
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing profits every quarter for the past 3 quarters
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers

Companies with growing costs YoY for long term projects
PE higher than Industry PE
High PE (PE > 40)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Declining Net Cash Flow : Companies not able to generate net cash
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter